The case for replacing live oral polio vaccine with inactivated vaccine in the Americas

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 395; no. 10230; pp. 1163 - 1166
Main Authors Alfaro-Murillo, Jorge A, Ávila-Agüero, Marí L, Fitzpatrick, Meagan C, Crystal, Caroline J, Falleiros-Arlant, Luiza-Helena, Galvani, Alison P
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 04.04.2020
Elsevier Limited
Subjects
Americas - epidemiology
Cost analysis
Costs
Economic analysis
Economic impact
Emergency response
Epidemics
Herd immunity
Humans
Immunity
Intestine
Measles
Morbidity
Outbreaks
Paralysis
Poliomyelitis
Poliomyelitis - epidemiology
Poliomyelitis - prevention & control
Poliovirus Vaccine, Inactivated
Poliovirus Vaccine, Oral
Public health
Risk assessment
Sanitation
Schedules
Seroconversion
Serotypes
Surveillance
Vaccination
Vaccines
Americas
Venezuela
United States > US
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(20)30213-0